Spots Global Cancer Trial Database for dexamethasone 4 mg
Every month we try and update this database with for dexamethasone 4 mg cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study of Pemetrexed+Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Participants With First Line Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-3475-189/KEYNOTE-189) | NCT02578680 | Non-Small-Cell ... | Pembrolizumab 2... Cisplatin Carboplatin Pemetrexed Folic acid 350-... Vitamin B12 100... Dexamethasone 4... Saline solution | 18 Years - | Merck Sharp & Dohme LLC | |
| Pembrolizumab Plus Bevacizumab and Chemotherapy for Non-Squamous NSCLC Patients | NCT05751187 | Non-squamous NS... | Pembrolizumab Bevacizumab Pemetrexed Cisplatin Carboplatin Folic acid 350-... Vitamin B12 100... Dexamethasone 4... | 18 Years - 75 Years | Shanghai Chest Hospital | |
| Pembrolizumab Plus Bevacizumab and Chemotherapy for Non-Squamous NSCLC Patients | NCT05751187 | Non-squamous NS... | Pembrolizumab Bevacizumab Pemetrexed Cisplatin Carboplatin Folic acid 350-... Vitamin B12 100... Dexamethasone 4... | 18 Years - 75 Years | Shanghai Chest Hospital | |
| KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated, Nonsquamous NSCLC | NCT04265534 | Non-Small Cell ... Non-squamous No... Non-Squamous No... KEAP1 Gene Muta... NRF2 Gene Mutat... NFE2L2 Gene Mut... | Telaglenastat Carboplatin Che... Pemetrexed Chem... Pembrolizumab I... Placebo Folic acid 400 ... Vitamin B12 100... Dexamethasone 4... | 18 Years - | Calithera Biosciences, Inc | |
| Pembrolizumab Plus Bevacizumab and Chemotherapy for Non-Squamous NSCLC Patients | NCT05751187 | Non-squamous NS... | Pembrolizumab Bevacizumab Pemetrexed Cisplatin Carboplatin Folic acid 350-... Vitamin B12 100... Dexamethasone 4... | 18 Years - 75 Years | Shanghai Chest Hospital | |
| Study of Pemetrexed+Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Participants With First Line Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-3475-189/KEYNOTE-189) | NCT02578680 | Non-Small-Cell ... | Pembrolizumab 2... Cisplatin Carboplatin Pemetrexed Folic acid 350-... Vitamin B12 100... Dexamethasone 4... Saline solution | 18 Years - | Merck Sharp & Dohme LLC | |
| Study of Pemetrexed+Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Participants With First Line Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-3475-189/KEYNOTE-189)-Japan Extension Study | NCT03950674 | Non-Small-Cell ... | Pembrolizumab 2... Cisplatin Carboplatin Pemetrexed Folic acid 350-... Vitamin B12 100... Dexamethasone 4... Saline solution | 18 Years - | Merck Sharp & Dohme LLC | |
| KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated, Nonsquamous NSCLC | NCT04265534 | Non-Small Cell ... Non-squamous No... Non-Squamous No... KEAP1 Gene Muta... NRF2 Gene Mutat... NFE2L2 Gene Mut... | Telaglenastat Carboplatin Che... Pemetrexed Chem... Pembrolizumab I... Placebo Folic acid 400 ... Vitamin B12 100... Dexamethasone 4... | 18 Years - | Calithera Biosciences, Inc |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
